In subgroups of patients, CSF levels of presynaptic neurexin 3 (NRXN3), postsynaptic neurogranin (NRGN) and Alzheimer’s disease biomarkers were measured for comparison. The gene discussed is NRXN3; the disease is early-onset autosomal dominant Alzheimer disease.